“Under these conditions, there does not seem to be a significant difference between the mortality rate of SARS-CoV-2 in OECD countries and that of common coronaviruses (χ2 test, P=0.11). Of course, the major flaw in this study is that the percentage of deaths attributable to the virus is not determined, but this is the case for all studies reporting respiratory virus infections, including SARS-CoV-2.”
“Under these conditions, and all other things being equal, SARS-CoV-2 infection cannot be described as being statistically more severe than infection with other coronaviruses in common circulation.”
“Finally, in OECD countries, SARS-CoV-2 does not seem to be deadlier than other circulating viruses.”
This is not the first time you've been called out on HN for quoting that outdated paper. The last time was 70 days ago (it was outdated 2+ months ago).
Another quote (from the abstract):
"It is concluded that the problem of SARS-CoV-2 is probably being overestimated, as 2.6 million people die of respiratory infections each year compared with less than 4000 deaths for SARS-CoV-2 at the time of writing. "
As of the Mar 19th 2020 issue of the Journal of Antimicrobial Agents.
Even without reading the paper, I can tell you that if this analysis were to be repeated, we would get different results, given that we are now (four months later) at 540,000 (confirmed, which is definitely an underestimate) deaths, rather than 4000.
Some quotes:
“Under these conditions, there does not seem to be a significant difference between the mortality rate of SARS-CoV-2 in OECD countries and that of common coronaviruses (χ2 test, P=0.11). Of course, the major flaw in this study is that the percentage of deaths attributable to the virus is not determined, but this is the case for all studies reporting respiratory virus infections, including SARS-CoV-2.”
“Under these conditions, and all other things being equal, SARS-CoV-2 infection cannot be described as being statistically more severe than infection with other coronaviruses in common circulation.”
“Finally, in OECD countries, SARS-CoV-2 does not seem to be deadlier than other circulating viruses.”